Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.
OBJECTIVE: To evaluate the efficacy and safety of tumor necrosis factor (TNF) inhibition with the p55 TNF receptor fusion protein (TNFr-Ig) for severe sight-threatening noninfectious posterior segment intraocular inflammation. METHODS: Seventeen patients with refractory noninfectious posterior segm...
Κύριοι συγγραφείς: | Murphy, C, Greiner, K, Plskova, J, Duncan, L, Frost, A, Isaacs, J, Rebello, P, Waldmann, H, Hale, G, Forrester, J, Dick, A |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2004
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Intravitreal steroid implants in the management of noninfectious intermediate and posterior uveitis
ανά: Sarjak M Shah, κ.ά.
Έκδοση: (2025-01-01) -
Intraocular therapy in noninfectious uveitis
ανά: Rocco Luigi Modugno, κ.ά.
Έκδοση: (2021-10-01) -
Emerging Therapies for Noninfectious Uveitis: What May Be Coming to the Clinics
ανά: Jose R. Maya, κ.ά.
Έκδοση: (2014-01-01) -
Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis
ανά: Swetha Palla, κ.ά.
Έκδοση: (2015-01-01) -
Campath-1H therapy in refractory ocular inflammatory disease.
ανά: Dick, A, κ.ά.
Έκδοση: (2000)